New Alzheimer's Drug Trial Shows Promise in Delaying Disease Progression
Donanemab may protect brain function for up to three years, according to findings presented at a major conference.
Donanemab may protect brain function for up to three years, according to findings presented at a major conference.
New trial data suggests the drug may preserve cognitive function and reduce brain damage in early-stage Alzheimer's.
New research suggests that adhering to a diet rich in fruits, vegetables, fish, and olive oil may bolster psychological well-being, even amidst challenging circumstances like the COVID-19 pandemic.
New research indicates a blood test measuring p-tau217 levels could identify individuals at high risk for cognitive impairment years in advance.
New research suggests a significant reduction in cardiovascular disease events and deaths could be achieved by decreasing consumption of ultra-processed foods.
New research presented at an international obesity congress indicates that reducing intake of items like crisps, biscuits, and ready meals could prevent thousands of cardiovascular events and deaths annually.
A naturally occurring plant compound, fisetin, is gaining traction among longevity experts for its potential to eliminate senescent cells, also known as 'zombie cells.'
High-priced fitness classes are reportedly leaving clients with a contagious fungal infection, prompting questions about hygiene protocols.
Amy Shapiro clarifies the role of cortisol and differentiates between effective management strategies and online misinformation.